Global Generative AI in Healthcare Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

Description

List of Tables

The global demand for Generative AI in Healthcare Market is presumed to reach the market size of nearly USD 34.13 Billion by 2032 from USD 2.6 Billion in 2023 with a CAGR of 33.12% under the study period 2024 - 2032.

Generative AI in healthcare is the application of generative models to create new and realistic data or content in the context of healthcare and medical applications. Generative AI models, particularly generative adversarial networks (GANs) and other similar architectures are designed to generate data that mimics the patterns and characteristics of the input data they were trained on.

MARKET DYNAMICS

Generative AI in the healthcare market is propelled by various factors that highlight the increasing integration of AI technologies in the healthcare sector. Key drivers include the technology's ability to address data challenges through data augmentation, particularly in the generation of diverse and representative datasets. Generative AI assists in advancing medical imaging by generating realistic images for diagnostic model training and enhancing accuracy. In drug discovery, the technology expedites the process by generating novel molecular structures and drug candidates. The personalization of treatment plans and the creation of realistic clinical scenarios for decision support contribute to its adoption. Privacy-preserving data generation, disease prediction simulations, and industry collaborations also drive market growth. Furthermore, the impact of the COVID-19 pandemic has accelerated the adoption of Generative AI in healthcare, particularly in tasks such as medical imaging analysis and drug discovery. Continuous advancements in computational capabilities and regulatory support further contribute to the expansion of this dynamic market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of generative ai in healthcare. The growth and trends of generative ai in healthcare industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the generative ai in healthcare market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Application

Personalized Treatment
Patient Assistance
Patient Monitoring And Predictive Analytics
Medical Image Analysis And Diagnostics
Drug Discovery And Development
Other

By End-Use

Healthcare Providers (Hospitals, Clinics, Diagnostic Centers, Other Healthcare Providers)
Pharmaceutical And Life Sciences Companies
Healthcare Payers

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Generative AI in Healthcare market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Generative AI in Healthcare market include Epic Systems Corporation, DiagnaMed Holdings Corp.,, Syntegra Medical Mind, IBM Watson Health Corporation, Google LLC, Oracle Corporation, Microsoft Corporation, Nvidia Corporation, Insilico Medicine, Abridge AI Inc., ELEKS, Persistent Systems. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR112113545

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . GENERATIVE AI IN HEALTHCARE - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Application
- 3.7.2 Market Attractiveness Analysis By End-use
- 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL GENERATIVE AI IN HEALTHCARE MARKET ANALYSIS BY APPLICATION

5.1 Overview by Application
5.2 Historical and Forecast Data
5.3 Analysis by Application
5.4 Personalized Treatment Historic and Forecast Sales by Regions
5.5 Patient Assistance Historic and Forecast Sales by Regions
5.6 Patient Monitoring And Predictive Analytics Historic and Forecast Sales by Regions
5.7 Medical Image Analysis And Diagnostics Historic and Forecast Sales by Regions
5.8 Drug Discovery And Development Historic and Forecast Sales by Regions
5.9 Other Historic and Forecast Sales by Regions

6 . GLOBAL GENERATIVE AI IN HEALTHCARE MARKET ANALYSIS BY END-USE

6.1 Overview by End-use
6.2 Historical and Forecast Data
6.3 Analysis by End-use
6.4 Healthcare Providers (Hospitals, Clinics, Diagnostic Centers, Other Healthcare Providers) Historic and Forecast Sales by Regions
6.5 Pharmaceutical And Life Sciences Companies Historic and Forecast Sales by Regions
6.6 Healthcare Payers Historic and Forecast Sales by Regions

7 . GLOBAL GENERATIVE AI IN HEALTHCARE MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1. Overview, Historic and Forecast Data Sales Analysis
- 7.3.2. North America By Segment Sales Analysis
- 7.3.3. North America By Country Sales Analysis
- 7.3.4. United State Sales Analysis
- 7.3.5. Canada Sales Analysis
- 7.3.6. Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1. Overview, Historic and Forecast Data Sales Analysis
- 7.4.2. Europe by Segment Sales Analysis
- 7.4.3. Europe by Country Sales Analysis
- 7.4.4. United Kingdom Sales Analysis
- 7.4.5. France Sales Analysis
- 7.4.6. Germany Sales Analysis
- 7.4.7. Italy Sales Analysis
- 7.4.8. Russia Sales Analysis
- 7.4.9. Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1. Overview, Historic and Forecast Data Sales Analysis
- 7.5.2. Asia Pacific by Segment Sales Analysis
- 7.5.3. Asia Pacific by Country Sales Analysis
- 7.5.4. China Sales Analysis
- 7.5.5. India Sales Analysis
- 7.5.6. Japan Sales Analysis
- 7.5.7. South Korea Sales Analysis
- 7.5.8. Australia Sales Analysis
- 7.5.9. South East Asia Sales Analysis
- 7.5.10. Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1. Overview, Historic and Forecast Data Sales Analysis
- 7.6.2. Latin America by Segment Sales Analysis
- 7.6.3. Latin America by Country Sales Analysis
- 7.6.4. Brazil Sales Analysis
- 7.6.5. Argentina Sales Analysis
- 7.6.6. Peru Sales Analysis
- 7.6.7. Chile Sales Analysis
- 7.6.8. Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1. Overview, Historic and Forecast Data Sales Analysis
- 7.7.2. Middle East & Africa by Segment Sales Analysis
- 7.7.3. Middle East & Africa by Country Sales Analysis
- 7.7.4. Saudi Arabia Sales Analysis
- 7.7.5. UAE Sales Analysis
- 7.7.6. Israel Sales Analysis
- 7.7.7. South Africa Sales Analysis
- 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE GENERATIVE AI IN HEALTHCARE COMPANIES

8.1. Generative Ai In Healthcare Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9 . COMPANY PROFILES OF GENERATIVE AI IN HEALTHCARE INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. Epic Systems Corporation
- 9.3.1. Company Overview
- 9.3.2. Company Revenue
- 9.3.3. Products
- 9.3.4. Recent Developments
9.4. DiagnaMed Holdings Corp.,
- 9.4.1. Company Overview
- 9.4.2. Company Revenue
- 9.4.3. Products
- 9.4.4. Recent Developments
9.5. Syntegra Medical Mind
- 9.5.1. Company Overview
- 9.5.2. Company Revenue
- 9.5.3. Products
- 9.5.4. Recent Developments
9.6. IBM Watson Health Corporation
- 9.6.1. Company Overview
- 9.6.2. Company Revenue
- 9.6.3. Products
- 9.6.4. Recent Developments
9.7. Google LLC
- 9.7.1. Company Overview
- 9.7.2. Company Revenue
- 9.7.3. Products
- 9.7.4. Recent Developments
9.8. Oracle Corporation
- 9.8.1. Company Overview
- 9.8.2. Company Revenue
- 9.8.3. Products
- 9.8.4. Recent Developments
9.9. Microsoft Corporation
- 9.9.1. Company Overview
- 9.9.2. Company Revenue
- 9.9.3. Products
- 9.9.4. Recent Developments
9.10. Nvidia Corporation
- 9.10.1. Company Overview
- 9.10.2. Company Revenue
- 9.10.3. Products
- 9.10.4. Recent Developments
9.11. Insilico Medicine
- 9.11.1. Company Overview
- 9.11.2. Company Revenue
- 9.11.3. Products
- 9.11.4. Recent Developments
9.12. Abridge AI Inc.
- 9.12.1. Company Overview
- 9.12.2. Company Revenue
- 9.12.3. Products
- 9.12.4. Recent Developments
9.13. ELEKS
- 9.13.1. Company Overview
- 9.13.2. Company Revenue
- 9.13.3. Products
- 9.13.4. Recent Developments
9.14. Persistent Systems
- 9.14.1. Company Overview
- 9.14.2. Company Revenue
- 9.14.3. Products
- 9.14.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies